]>
IRCT20210602051475N1 IRCT 2021-06-21 Sabzevar University of Medical Sciences Comparison of therapeutic effect of prostatan (nettle) and pumpkin extract in a patient with benign prostatic hyperplasia Comparison of therapeutic effect of prostatan (nettle) and pumpkin extract in a patient with benign prostatic hyperplasia 2021-06-02 anticipated 100 Complete https://irct.ir/trial/56653 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Factorial, Purpose: Treatment, Randomization description: Random permutation block, which is one of the randomization methods in studies, is block randomization, in this method, usually the number of people assigned to each group is almost equal. In this method, blocks are formed based on the considered variables and within each block, half of the people are involved and half are considered as controls. Samples will be determined by random land block method with 4 blocks and using random numbers table of Random allocation software, Blinding description: This study is a double-blind clinical trial in such a way that for each person in the study, code '1' and '2' will be assigned that only the researcher will be aware of the type of groups and the participants and the treating physician groups are uninformed. 3 Benign prostatic hyperplasia. Intervention 1: Control group: standard treatment includes tamsulosin 0.4 mg capsules daily for two months. Intervention 2: Intervention group: tamsulosin capsules 0.4 mg daily and pumpkin drops 10 drops daily for two months. Yes - There is a plan to make this available What will be shared: Only part of the data, such as the original outcome information, can be shared When: After printing the results To whom: Researchers working in academic and scientific institutions Conditions: Researchers working in academic and scientific institutions Where to obtain: reyhaneh sedigh 00989385167434 rsedigh@97gmail.com How to obtain: After printing the results Comments:
public Reyhaneh Sedigh
Sabzevar University of Medical Sciences, Shohada Hasteie Boulevard
sabzevar Iran (Islamic Republic of) 9617913112 +98 51 4401 8101 rsedigh97@gmail.com Sabzevar University of Medical Sciences scientific Dr. Hamidreza Baghaniaval
Sabzevar University of Medical Sciences, Shohada Hasteie Boulevard
sabzevar Iran (Islamic Republic of) 9617913112 +98 51 4401 8101 rsedigh@gmail.com Sabzevar University of Medical Sciences Iran (Islamic Republic of) Age over 50 years old Benign prostate enlargement Administrative detention Frequent urination 50 years no limit Male Existence of urological disease other than benign prostate enlargement Need immediate surgical intervention for treatment Use of BPH-related drugs (stimulants and aggravators) in the last six months N40 Enlarged prostate Treatment - Drugs Treatment - Drugs Control group: standard treatment includes tamsulosin 0.4 mg capsules daily for two months Intervention group: tamsulosin capsules 0.4 mg daily and pumpkin drops 10 drops daily for two months Decreased PSA levels during treatment. Timepoint: In the times before the intervention (0), two weeks, four weeks and eight weeks after the intervention, the questionnaire will be filled in by the participants in the project. Method of measurement: World Standard Scale for Symptoms of Prostate Hyperplasia and Uflometry. Sabzevar University of Medical Sciences Approved 2021-05-30 Ethics Committee of Sabzevar University of Medical Sciences Sabzevar University of Medical Sciences, Shohada Hasteie Boulevard Sabzvar Razavi Khorasan Iran (Islamic Republic of)